WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION |
Return to index |
|
|
|
|
|
Order |
Gene |
Description |
ref_hepatocyte |
HepG2 |
HepG2.C3A |
HuH.7 |
SNU475 |
THLE |
liver |
1 |
PDE6D |
Retinal rod rhodopsin-sensitive cGMP
3',5'-cyclic phosphodiesterase subunit delta |
-2.35[1] |
-3.49[2] |
-2.33[3] |
-2.08[4] |
-1.99[5] |
-3.90[6] |
2 |
PDE8A |
High affinity cAMP-specific and
IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A |
-0.88[7] |
-0.59[8] |
-0.68[9] |
-1.60[10] |
-1.31[11] |
-0.87[12] |
3 |
PDE12 |
2',5'-phosphodiesterase 12 |
[13] |
-0.62[14] |
-1.08[15] |
-2.59[16] |
-1.27[17] |
-0.50[18] |
-0.99[19] |
4 |
PDE3B |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
[20] |
-0.77[21] |
-0.12[22] |
-0.29[23] |
-2.70[24] |
-3.37[25] |
0.47[26] |
5 |
ADCY9 |
Adenylate cyclase type 9 |
[27] |
1.40[28] |
0.28[29] |
0.28[30] |
-0.36[31] |
-1.05[32] |
0.01[33] |
6 |
ADCY6 |
Adenylate cyclase type 6 |
[34] |
0.83[35] |
0.98[36] |
0.52[37] |
1.19[38] |
1.63[39] |
0.23[40] |
7 |
CREB1 |
Cyclic AMP-responsive element-binding protein 1 |
[41] |
0.50[42] |
1.35[43] |
1.42[44] |
1.23[45] |
0.94[46] |
-0.06[47] |
8 |
ADORA2A |
Adenosine receptor A2a |
[48] |
-1.80[49] |
-1.64[50] |
-0.34[51] |
-1.92[52] |
-3.96[53] |
-1.21[54] |
9 |
PDE9A |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
[55] |
0.14[56] |
0.57[57] |
-0.15[58] |
-5.30[59] |
-6.27[60] |
-3.20[61] |
10 |
ADCY1 |
Adenylate cyclase type 1 |
[62] |
-2.06[63] |
-4.24[64] |
-4.86[65] |
-3.42[66] |
-3.67[67] |
2.59[68] |
11 |
PDE7A |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A |
[69] |
0.77[70] |
1.05[71] |
1.12[72] |
2.46[73] |
0.87[74] |
-0.21[75] |
12 |
ADCY7 |
Adenylate cyclase type 7 |
[76] |
2.29[77] |
1.60[78] |
0.14[79] |
1.99[80] |
1.24[81] |
0.52[82] |
13 |
PDE4C |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C |
[83] |
1.75[84] |
0.88[85] |
-1.04[86] |
-2.51[87] |
-1.06[88] |
-3.27[89] |
14 |
PDE4A |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A |
[90] |
1.90[91] |
0.52[92] |
1.47[93] |
-0.72[94] |
1.89[95] |
-0.89[96] |
15 |
PDE4B |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B |
[97] |
[98] |
[99] |
-7.71[100] |
-0.53[101] |
1.89[102] |
0.03[103] |
16 |
PDE2A |
cGMP-dependent 3',5'-cyclic phosphodiesterase |
[104] |
0.30[105] |
-6.21[106] |
-5.57[107] |
-4.90[108] |
-0.82[109] |
2.46[110] |
17 |
ADCY10 |
Adenylate cyclase type 10 |
[111] |
-3.42[112] |
-4.61[113] |
1.11[114] |
-2.27[115] |
-5.30[116] |
0.37[117] |
18 |
PDE11A |
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A |
[118] |
0.92[119] |
-0.16[120] |
0.09[121] |
1.73[122] |
-4.23[123] |
2.01[124] |
19 |
PDE5A |
cGMP-specific 3',5'-cyclic phosphodiesterase |
[125] |
-1.33[126] |
-0.34[127] |
1.03[128] |
2.62[129] |
0.67[130] |
0.58[131] |
20 |
PDE6B |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta |
[132] |
-2.18[133] |
-2.90[134] |
-4.23[135] |
0.13[136] |
-3.29[137] |
-1.68[138] |
21 |
PDE6A |
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha |
[139] |
-1.16[140] |
-0.79[141] |
-1.16[142] |
0.15[143] |
0.16[144] |
-0.92[145] |
22 |
PDE4D |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D |
[146] |
2.23[147] |
5.06[148] |
4.74[149] |
3.26[150] |
4.26[151] |
2.33[152] |
23 |
ADCY3 |
Adenylate cyclase type 3 |
[153] |
0.24[154] |
-1.32[155] |
1.59[156] |
3.42[157] |
4.72[158] |
1.11[159] |
24 |
CHRNA7 |
Neuronal acetylcholine receptor subunit alpha-7 |
[160] |
-0.08[161] |
-0.60[162] |
-4.66[163] |
-0.25[164] |
-1.25[165] |
-3.57[166] |
25 |
PDE7B |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
[167] |
-3.47[168] |
-3.31[169] |
-2.77[170] |
3.39[171] |
4.71[172] |
2.38[173] |
26 |
PPP1R1B |
Protein phosphatase 1 regulatory subunit 1B |
[174] |
-2.80[175] |
-3.99[176] |
-8.36[177] |
-4.67[178] |
-1.03[179] |
-4.68[180] |
27 |
ADCY2 |
Adenylate cyclase type 2 |
[181] |
-6.60[182] |
-4.98[183] |
-6.66[184] |
-4.05[185] |
-5.40[186] |
-6.52[187] |
28 |
NOS1 |
Nitric oxide synthase, brain |
[188] |
-2.77[189] |
-1.12[190] |
-3.11[191] |
-1.99[192] |
-2.32[193] |
-1.71[194] |
29 |
PDE1B |
Calcium/calmodulin-dependent
3',5'-cyclic nucleotide phosphodiesterase 1B |
-4.90[195] |
-6.19[196] |
[197] |
-2.13[198] |
-3.45[199] |
1.46[200] |
30 |
GRIN2D |
Glutamate receptor ionotropic, NMDA 2D |
[201] |
3.27[202] |
2.85[203] |
2.75[204] |
1.47[205] |
0.19[206] |
-2.46[207] |
31 |
PDE8B |
High affinity cAMP-specific and
IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B |
-0.07[208] |
0.07[209] |
-0.51[210] |
0.41[211] |
-0.74[212] |
1.65[213] |
32 |
ADCY5 |
Adenylate cyclase type 5 |
[214] |
-1.07[215] |
-0.38[216] |
0.23[217] |
-0.66[218] |
0.23[219] |
3.97[220] |
33 |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
[221] |
0.61[222] |
2.46[223] |
6.77[224] |
2.26[225] |
3.35[226] |
4.15[227] |
34 |
GRIN2B |
Glutamate receptor ionotropic, NMDA 2B |
[228] |
-3.68[229] |
[230] |
[231] |
-0.23[232] |
-3.27[233] |
-0.54[234] |
35 |
PDE6G |
Retinal rod rhodopsin-sensitive cGMP
3',5'-cyclic phosphodiesterase subunit gamma |
3.57[235] |
4.41[236] |
-1.08[237] |
1.67[238] |
-0.25[239] |
0.68[240] |
36 |
PDE1A |
Calcium/calmodulin-dependent
3',5'-cyclic nucleotide phosphodiesterase 1A |
[241] |
-2.25[242] |
2.03[243] |
4.80[244] |
1.03[245] |
4.20[246] |
37 |
CHRFAM7A |
CHRNA7-FAM7A fusion protein |
[247] |
1.37[248] |
0.94[249] |
-5.15[250] |
1.93[251] |
0.96[252] |
-2.05[253] |
38 |
PDE6C |
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' |
[254] |
-0.70[255] |
1.85[256] |
-1.13[257] |
-3.01[258] |
-2.45[259] |
-1.07[260] |
39 |
GRIA1 |
Glutamate receptor 1 |
[261] |
-3.55[262] |
[263] |
[264] |
-1.97[265] |
-1.76[266] |
-2.26[267] |
40 |
GUCY1A2 |
Guanylate cyclase soluble subunit alpha-2 |
[268] |
0.03[269] |
0.82[270] |
6.08[271] |
8.91[272] |
3.22[273] |
8.17[274] |
41 |
GRIN2C |
Glutamate receptor ionotropic, NMDA 2C |
[275] |
2.37[276] |
3.71[277] |
1.89[278] |
2.17[279] |
2.57[280] |
1.54[281] |
42 |
ADCY4 |
Adenylate cyclase type 4 |
[282] |
-1.13[283] |
-2.51[284] |
-0.29[285] |
[286] |
[287] |
5.97[288] |
43 |
PDE10A |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
[289] |
-1.92[290] |
[291] |
[292] |
1.06[293] |
7.16[294] |
5.13[295] |
44 |
GRIN2A |
Glutamate receptor ionotropic, NMDA 2A |
[296] |
[297] |
[298] |
-2.56[299] |
7.74[300] |
0.04[301] |
5.63[302] |
45 |
PDE1C |
Calcium/calmodulin-dependent
3',5'-cyclic nucleotide phosphodiesterase 1C |
[303] |
[304] |
[305] |
[306] |
[307] |
[308] |
46 |
DRD1 |
D(1A) dopamine receptor |
[309] |
[310] |
[311] |
[312] |
[313] |
[314] |
[315] |
47 |
GUCY1B1 |
|
[316] |
[317] |
[318] |
[319] |
[320] |
[321] |
[322] |
48 |
GUCY1B2 |
Guanylate cyclase soluble subunit beta-2 |
[323] |
[324] |
[325] |
[326] |
[327] |
[328] |
[329] |
49 |
GUCY1A1 |
|
[330] |
[331] |
[332] |
[333] |
[334] |
[335] |
[336] |
50 |
GRIN1 |
Glutamate receptor ionotropic, NMDA 1 |
[337] |
[338] |
[339] |
[340] |
[341] |
[342] |
[343] |
51 |
PDE6H |
Retinal cone rhodopsin-sensitive
cGMP 3',5'-cyclic phosphodiesterase subunit gamma |
[344] |
[345] |
[346] |
[347] |
[348] |
52 |
ENSG00000284797 |
[349] |
[350] |
[351] |
[352] |
[353] |
[354] |
[355] |
53 |
ADCY8 |
Adenylate cyclase type 8 |
[356] |
[357] |
[358] |
[359] |
[360] |
[361] |
[362] |
54 |
DRD2 |
D(2) dopamine receptor |
[363] |
[364] |
[365] |
[366] |
[367] |
[368] |
[369] |
|
|
|
|
|
|
|
|
|
|